Upgrade to SI Premium - Free Trial

Cognex Reports Strong Results for the Third Quarter of 2020

October 28, 2020 4:06 PM

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2020. Table 1 below shows selected financial data for Q3-20 compared with Q3-19 and Q2-20, and for the nine months ended September 27, 2020 compared with the same period in 2019.

Table 1

(Dollars in thousands, except per share amounts)

Revenue

Net
Income/(Loss)

Net
Income/(Loss)
per Diluted
Share

Non-GAAP
Net Income
per Diluted
Share*

Quarterly Comparisons

Current quarter: Q3-20

$251,073

$87,506

$0.49

$0.47

Prior year’s quarter: Q3-19

$183,325

$41,685

$0.24

$0.24

Change: Q3-19 to Q3-20

37%

110%

104%

96%

Prior quarter: Q2-20

$169,097

$(1,142)

$(0.01)

$0.18

Change: Q2-20 to Q3-20

48%

N/M

N/M

161%

Year-to-Date Comparisons

Nine months ended Sept. 27, 2020

$587,405

$106,841

$0.61

$0.77

Nine months ended Sept. 29, 2019

$555,856

$123,538

$0.71

$0.69

Change from first nine months of 2019 to first nine months of 2020

6%

(14)%

(14)%

12%

*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred predominantly in Q2-20, and tax adjustments for all periods presented. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“Our results for Q3-20 were very good and above our expectations,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “We reported the second-highest quarterly revenue, net income and earnings per share from continuing operations in our company’s 39-year history. We were also highly profitable—reporting an operating margin of 38% in Q3-20 compared to 24% a year ago—due to the leverage in our business model.”

“We are proud of the substantial revenue growth and operating margin expansion that we achieved this quarter,” said Robert J. Willett, Chief Executive Officer of Cognex. “They reflect our success in meeting the sudden increase in demand from certain large customers during the quarter. It is very gratifying to see the tangible results of the hard work by the entire Cognex team during these challenging times.”

Details of the Quarter

Statement of Operations Highlights – Third Quarter of 2020

Balance Sheet Highlights – September 27, 2020

Financial Outlook – Q4 2020

Non-GAAP Financial Measures

Analyst Conference Call and Simultaneous Webcast

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 2.3 million image-based products, representing over $7 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on Cognex’s assets, business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost savings initiatives, research and development activities, stock repurchases, investments, liquidity, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include (1) the impact, duration, and severity of the COVID-19 pandemic; (2) current and future conditions in the global economy, including the impact of the COVID-19 pandemic and the imposition of tariffs or export controls; (3) the loss of, or curtailment of purchases by, a large customer; (4) the reliance on revenue from the consumer electronics or automotive industries; (5) the inability to penetrate the logistics industry and other new markets; (6) the inability to achieve significant international revenue; (7) fluctuations in foreign currency exchange rates and the use of derivative instruments; (8) information security breaches or business system disruptions; (9) the inability to attract and retain skilled employees; (10) the failure to effectively manage our growth; (11) the reliance upon key suppliers to manufacture and deliver critical components for our products; (12) the failure to effectively manage product transitions or accurately forecast customer demand; (13) the inability to design and manufacture high-quality products; (14) the technological obsolescence of current products and the inability to develop new products; (15) the failure to properly manage the distribution of products and services; (16) the inability to protect our proprietary technology and intellectual property; (17) our involvement in time-consuming and costly litigation; (18) the impact of competitive pressures; (19) the challenges in integrating and achieving expected results from acquired businesses, including the acquisition of Sualab; (20) potential impairment charges with respect to our investments or for acquired intangible assets or goodwill; (21) exposure to additional tax liabilities; and (22) potential disruptions to our business due to restructuring activities and the failure of such activities to generate the anticipated cost savings; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2019 and Form 10-Q for the fiscal quarter ended September 27, 2020. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

COGNEX CORPORATION

Statements of Operations

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

Nine-months Ended

Sept. 27, 2020

Jun. 28, 2020

Sept. 29, 2019

Sept. 27, 2020

Sept. 29, 2019

Revenue

$

251,073

$

169,097

$

183,325

$

587,405

$

555,856

Cost of revenue (1)

59,741

50,320

47,632

151,261

144,883

Gross margin

191,332

118,777

135,693

436,144

410,973

Percentage of revenue

76

%

70

%

74

%

74

%

74

%

Research, development, and engineering
expenses (1)

30,240

30,397

28,115

96,583

86,436

Percentage of revenue

12

%

18

%

15

%

16

%

16

%

Selling, general, and administrative expenses (1)

64,206

60,153

64,486

193,497

199,542

Percentage of revenue

26

%

36

%

35

%

33

%

36

%

Restructuring charges

251

14,798

15,049

Intangible asset impairment charges

19,571

19,571

Operating income (loss)

96,635

(6,142)

43,092

111,444

124,995

Percentage of revenue

38

%

(4)

%

24

%

19

%

22

%

Foreign currency gain (loss)

2,357

336

(1,295)

(310)

(1,403)

Investment and other income

2,317

3,494

5,570

10,857

16,481

Income (loss) before income tax expense (benefit)

101,309

(2,312)

47,367

121,991

140,073

Income tax expense (benefit)

13,803

(1,170)

5,682

15,150

16,535

Net income (loss)

$

87,506

$

(1,142)

$

41,685

$

106,841

$

123,538

Percentage of revenue

35

%

(1)

%

23

%

18

%

22

%

Net income (loss) per weighted-average common and common-equivalent share:

Basic

$

0.50

$

(0.01)

$

0.24

$

0.62

$

0.72

Diluted

$

0.49

$

(0.01)

$

0.24

$

0.61

$

0.71

Weighted-average common and common-equivalent shares outstanding:

Basic

173,943

172,283

170,744

172,881

171,053

Diluted

177,138

172,283

174,449

176,038

175,164

Cash dividends per common share

$

0.055

$

0.055

$

0.050

$

0.165

$

0.150

Cash and investments per common share

$

5.80

$

5.18

$

5.37

$

5.80

$

5.37

Book value per common share

$

8.62

$

7.95

$

7.25

$

8.62

$

7.25

(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$

324

$

363

$

334

$

1,041

$

1,114

Research, development, and engineering

2,815

2,401

3,616

10,582

11,633

Selling, general, and administrative

6,129

5,254

6,244

20,453

20,695

Total stock-based compensation expense

$

9,268

$

8,018

$

10,194

$

32,076

$

33,442

Exhibit 2

COGNEX CORPORATION

Reconciliation of Selected Items from GAAP to Non-GAAP

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended Nine-months Ended
Sept. 27, 2020 Jun. 28, 2020 Sept. 29, 2019 Sept. 27, 2020 Sept. 29, 2019
Adjustment for stock expense and tax benefit for stock exercises
Operating income (loss) (GAAP) $

96,635

$

(6,142

) $

43,092

$

111,444

$

124,995

Stock-based compensation expense

9,268

8,018

10,194

32,076

33,442

Operating income (Non-GAAP) $

105,903

$

1,876

$

53,286

$

143,520

$

158,437

Percentage of revenue (Non-GAAP)

42

%

1

%

29

%

24

%

29

%

Net income (loss) (GAAP) $

87,506

$

(1,142

) $

41,685

$

106,841

$

123,538

Stock-based compensation expense

9,268

8,018

10,194

32,076

33,442

Tax effect on stock-based compensation expense

(1,524

)

(1,277

)

(1,804

)

(5,365

)

(5,839

)

Discrete tax benefit related to stock-based compensation

(4,354

)

(4,413

)

(569

)

(10,447

)

(4,547

)

Net income (Non-GAAP) $

90,896

$

1,186

$

49,506

$

123,105

$

146,594

Percentage of revenue (Non-GAAP)

36

%

1

%

27

%

21

%

26

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) $

0.49

$

(0.01

) $

0.24

$

0.61

$

0.71

Per share impact of non-GAAP adjustments identified above

0.02

0.02

0.04

0.09

0.13

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) $

0.51

$

0.01

$

0.28

$

0.70

$

0.84

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

177,138

175,403

174,449

176,038

175,164

Exclusion of tax adjustments

Income (loss) before income tax expense (benefit) (GAAP) $

101,309

$

(2,312

) $

47,367

$

121,991

$

140,073

Income tax expense (benefit) (GAAP) $

13,803

$

(1,170

) $

5,682

$

15,150

$

16,535

Effective tax rate (GAAP)

14

%

(51

)%

12

%

12

%

12

%

Tax adjustments:

Discrete tax benefit related to stock-based compensation

4,354

4,413

569

10,447

4,547

Discrete tax benefit (expense) related to tax return filings and other

(129

)

(3,267

)

1,327

(3,638

)

1,330

Tax rate adjustment

(415

)

Income tax expense (benefit) (Non-GAAP) $

18,028

$

(439

) $

7,578

$

21,959

$

22,412

Effective tax rate (Non-GAAP)

18

%

(19

)%

16

%

18

%

16

%

Net income (loss) (Non-GAAP) $

83,281

$

(1,873

) $

39,789

$

100,032

$

117,661

Percentage of revenue (Non-GAAP)

33

%

(1

)%

22

%

17

%

21

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) $

0.49

$

(0.01

) $

0.24

$

0.61

$

0.71

Per share impact of non-GAAP adjustments identified above

(0.02

)

(0.01

)

(0.04

)

(0.04

)

Net income (loss) per diluted weighted-average common and common-equivalent share (Non-GAAP) $

0.47

$

(0.01

) $

0.23

$

0.57

$

0.67

Diluted weighted-average common and common-equivalent shares outstanding (GAAP)

177,138

172,283

174,449

176,038

175,164

Three-months Ended Nine-months Ended
Sept. 27, 2020 Jun. 28, 2020 Sept. 29, 2019 Sept. 27, 2020 Sept. 29, 2019
Exclusion of restructuring and other charges
Gross margin (GAAP) $

191,332

$

118,777

$

135,693

$

436,144

$

410,973

Excess and obsolete inventory charges

603

7,718

2,409

9,386

4,121

Gross margin (Non-GAAP) $

191,935

$

126,495

$

138,102

$

445,530

$

415,094

Percentage of revenue (Non-GAAP)

76

%

75

%

75

%

76

%

75

%

Operating income (loss) (GAAP) $

96,635

$

(6,142)

$

43,092

$

111,444

$

124,995

Excess and obsolete inventory charges

603

7,718

2,409

9,386

4,121

Restructuring charges

251

14,798

15,049

Intangible asset impairment charges

19,571

19,571

Operating income (Non-GAAP) $

97,489

$

35,945

$

45,501

$

155,450

$

129,116

Percentage of revenue (Non-GAAP)

39

%

21

%

25

%

26

%

23

%

Net income (loss) (GAAP) $

87,506

$

(1,142

) $

41,685

$

106,841

$

123,538

Excess and obsolete inventory charges

603

7,718

2,409

9,386

4,121

Restructuring charges

251

14,798

15,049

Intangible asset impairment charges

19,571

19,571

Tax effect on restructuring and other charges

(154

)

(7,997

)

(385

)

(7,921

)

(659

)

Net income (Non-GAAP) $

88,206

$

32,948

$

43,709

$

142,926

$

127,000

Percentage of revenue (Non-GAAP)

35

%

19

%

24

%

24

%

23

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) $

0.49

$

(0.01

) $

0.24

$

0.61

$

0.71

Per share impact of non-GAAP adjustments identified above

0.01

0.20

0.01

0.20

0.02

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) $

0.50

$

0.19

$

0.25

$

0.81

$

0.73

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

177,138

175,403

174,449

176,038

175,164

Three-months Ended Nine-months Ended
Sept. 27, 2020 Jun. 28, 2020 Sept. 29, 2019 Sept. 27, 2020 Sept. 29, 2019
Exclusion of restructuring and other charges and tax adjustments
Net income (loss) (GAAP) $

87,506

$

(1,142

) $

41,685

$

106,841

$

123,538

Excess and obsolete inventory charges

603

7,718

2,409

9,386

4,121

Restructuring charges

251

14,798

15,049

Intangible asset impairment charges

19,571

19,571

Tax effect on restructuring and other charges

(154

)

(7,997

)

(385

)

(7,921

)

(659

)

Tax adjustments

(4,225

)

(731

)

(1,896)

(6,809

)

(5,877

)

Net income (Non-GAAP) $

83,981

$

32,217

$

41,813

$

136,117

$

121,123

Percentage of revenue (Non-GAAP)

33

%

19

%

23

%

23

%

22

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) $

0.49

$

(0.01

) $

0.24

$

0.61

$

0.71

Per share impact of non-GAAP adjustments identified above

(0.02

)

0.19

0.16

(0.02

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) $

0.47

$

0.18

$

0.24

$

0.77

$

0.69

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

177,138

175,403

174,449

176,038

175,164

Exhibit 3

COGNEX CORPORATION

Balance Sheets

(Unaudited)

Dollars in thousands

Sept. 27, 2020

December 31, 2019

Assets

Cash and investments

$

1,013,064

$

845,353

Accounts receivable

127,755

103,447

Inventories

53,860

60,261

Property, plant, and equipment

81,225

89,443

Operating lease assets

24,942

17,522

Goodwill and intangible assets

259,611

282,935

Deferred tax assets

439,574

449,519

Other assets

60,484

37,455

Total assets

$

2,060,515

$

1,885,935

Liabilities and Shareholders' Equity

Accounts payable and accrued expenses

$

89,812

$

70,065

Deferred revenue and customer deposits

33,717

14,432

Operating lease liabilities

27,916

17,973

Income taxes

68,246

93,009

Deferred tax liabilities

326,703

332,344

Other liabilities

8,292

2,402

Shareholders' equity

1,505,829

1,355,710

Total liabilities and shareholders' equity

$

2,060,515

$

1,885,935

Susan Conway

Investor Relations

+1 508-650-3353

[email protected]

Source: Cognex Corporation

Categories

Business Wire Press Releases

Next Articles